Saudi Pharmaceutical Industries and Medical Appliances Corporation Stock
Equities
2070
SA0007879188
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.92 SAR | -0.66% |
|
+8.33% | +14.81% |
| 01-04 | Spimaco Forms Biopharmaceutical Manufacturing Subsidiary | MT |
| 01-04 | Spimaco establishes subsidiary "Spimaco Bio" for manufacturing of biopharmaceutical products | RE |
| Capitalization | 3.57B 952M 806M 739M 700M 1.3B 86.27B 1.36B 8.59B 3.4B 41.53B 3.5B 150B | P/E ratio 2025 * |
24.1x | P/E ratio 2026 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise value | 4.69B 1.25B 1.06B 971M 919M 1.71B 113B 1.78B 11.28B 4.47B 54.56B 4.6B 196B | EV / Sales 2025 * |
2.66x | EV / Sales 2026 * | 2.35x |
| Free-Float |
79% | Yield 2025 * |
-
| Yield 2026 * | 1.69% |
| 1 day | -0.66% | ||
| 1 week | +8.33% | ||
| Current month | +8.33% | ||
| 1 month | +18.54% | ||
| 3 months | -3.11% | ||
| 6 months | +14.99% | ||
| Current year | +14.81% |
| 1 week | 26.42 |  | 31.66 |
| 1 month | 26.22 | | 31.66 |
| Current year | 24.96 | | 31.66 |
| 1 year | 20.94 | | 33.2 |
| 3 years | 20.94 | | 45.25 |
| 5 years | 20.94 | | 61.4 |
| 10 years | 20.94 | | 61.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 05/01/2021 | |
Jan-Olav Henck
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jerome Cabannes
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 03/04/2016 | |
Faisal Shaker
BRD | Director/Board Member | - | 03/04/2019 |
| Director/Board Member | - | 03/04/2019 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +0.90% | 0% | 34 M€ | |
| +0.45% | 0% | 14 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.66% | +8.33% | -10.02% | +30.09% | 959M | |
| +3.66% | +2.03% | +20.48% | +211.52% | 947B | |
| +0.93% | +5.61% | +56.73% | +46.87% | 578B | |
| +2.01% | +0.19% | +17.22% | +53.94% | 395B | |
| -0.64% | +1.63% | +23.32% | +25.27% | 367B | |
| +1.82% | +10.57% | +39.70% | +15.38% | 303B | |
| +0.89% | +3.71% | +21.59% | +33.23% | 298B | |
| +0.57% | +4.66% | +23.89% | +51.27% | 295B | |
| +5.29% | -20.04% | -53.01% | -38.83% | 208B | |
| +4.49% | +12.41% | +30.93% | +57.51% | 207B | |
| Average | +1.84% | +2.88% | +17.08% | +48.63% | 359.82B | |
| Weighted average by Cap. | +2.11% | +2.60% | +24.58% | +81.05% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.76B 470M 398M 365M 345M 641M 42.58B 670M 4.24B 1.68B 20.5B 1.73B 73.79B | 1.97B 526M 445M 408M 386M 718M 47.65B 750M 4.74B 1.88B 22.94B 1.93B 82.58B |
| Net income | 149M 39.73M 33.63M 30.82M 29.19M 54.2M 3.6B 56.67M 358M 142M 1.73B 146M 6.24B | 193M 51.48M 43.58M 39.94M 37.83M 70.24M 4.66B 73.44M 464M 184M 2.25B 189M 8.08B |
| Net Debt | 1.12B 299M 253M 232M 220M 408M 27.08B 426M 2.69B 1.07B 13.03B 1.1B 46.92B | 1.07B 286M 242M 222M 210M 391M 25.95B 409M 2.58B 1.02B 12.49B 1.05B 44.98B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/02/26 | 29.92 ﷼ | -0.66% | 998,797 |
| 05/02/26 | 30.12 ﷼ | +1.07% | 934,051 |
| 04/02/26 | 29.80 ﷼ | +0.40% | 565,221 |
| 03/02/26 | 29.68 ﷼ | +2.56% | 1,054,268 |
| 02/02/26 | 28.94 ﷼ | +7.26% | 930,118 |
Delayed Quote Saudi Arabian S.E., February 08, 2026 at 03:20 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 2070 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition